Rapid Colorimetric Method for Testing Susceptibility of Mycobacterium tuberculosis to Isoniazid and Rifampin in Liquid Cultures

Journal of Clinical Microbiology

Volumn 41, Issue 11, 2003, Pages 5173-5177

  Syre, H ^a   Phyu, S ^a   Sandven, P ^b   Bjorvatn, B ^a   Grewal, H M S ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ANALYTIC METHOD; ANTIBIOTIC SENSITIVITY; ARTICLE; COLORIMETRIC NITRATE REDUCTASE BASED ANTIBIOTIC SUSCEPTIBILITY; COLORIMETRY; CONTROLLED STUDY; INTERMETHOD COMPARISON; LIQUID CULTURE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RADIOMETRY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD;

ANTITUBERCULAR AGENTS; COLORIMETRY; DRUG RESISTANCE, BACTERIAL; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; NITRITES; REPRODUCIBILITY OF RESULTS; RIFAMPIN; TIME FACTORS; TUBERCULOSIS;

ACTINOBACTERIA (CLASS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0242509121     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.11.5173-5177.2003     Document Type: Article

References (24)

1. Altman, D. G. 1999. Inter-rater agreement, p. 403-409. In D. G. Altman (ed.), Practical statistics for medical research. Chapman & Hall/CRC, London, United Kingdom.
2. Ängeby, K. A. K., L. Klintz, and S. E. Hoffner. 2002. Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J. Clin. Microbiol. 40:553-555.
3. Caviedes, L., J. Delgado, and R. H. Gilman. 2002. Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis. J. Clin. Microbiol. 40:1873-1874.
4. Caviedes, L., T. Lee, R. H. Gilman, P. Sheen, E. Spellman, E. H. Lee, D. E. Berg, S. Montenegro-James, and The Tuberculosis Working Group in Peru. 2000. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. J. Clin. Microbiol. 38:1203-1208.
5. Deeks, J. J. 2001. Systematic reviews of evaluations of diagnostic and screening tests. BMJ 323:157-162.
6. Goloubeva, V., M. Lecocq, P. Lassowsky, F. Matthys, F. Portaels, and I. Bastian. 2001. Evaluation of Mycobacteria Growth Indicator Tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital. J. Clin. Microbiol. 39:1501-1505.
7. Inderlied, C. B., and M. Salfinger. 1999. Antimycobacterial agents and susceptibility test, p. 1601-1623. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.
8. Jaeschke, R., G. H. Guyatt, D. L. Sackett, et al. 1994. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? JAMA 271:703-707.
9. Kent, P. T., and G. P. Kubica. 1985. Public health mycobacteriology. A guide for the level III laboratory, p. 96-103. U.S. Department of Health and Human Services, Atlanta, Ga.
10. Kilburn, J. O., and K. Takayama. 1981. Effects of ethambutol on accumulation and secretion of trehalose mycolates and free mycolic acids in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 20:401-404.
11. Laszlo, A., M. Rahman, M. Raviglione, and F. Bustreo. 1998. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Int. J. Tuberc. Lung Dis. 2:69-70.
12. Master, R. N. 1992. Identification tests for mycobacteria, part 3.122, p. 1-29. In H. O. Isenberg (ed.), Clinical microbiology procedures handbook, vol. 1. American Society for Microbiology, Washington, D.C.
13. Mshana, R. N., G. Tadesse, G. Abate, and H. Miørner. 1998. Use of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 36:1214-1219.
14. Nachamkin, I., C. Kang, and M. P. Weinstein. 1997. Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. Clin. Infect. Dis. 24:894-900.
15. Palomino, J. C., and F. Portaels. 1999. Simple procedure for drug susceptibility testing of Mycobacterium tuberculosis using a commercial colorimetric assay. Eur. J. Clin. Microbiol. Infect. Dis. 18:380-383.
16. Phyu, S., T. Ti, R. Jureen, T. Mmun, H. Myint, A. Tun, H. M. S. Grewal, and B. Bjorvatn. 2003. Drug resistant tuberculosis among new patients in Yangon, Myanmar. Emerg. Infect. Dis. 9:274-276.
17. Roberts, G. D., N. L. Goodman, L. Heifets, H. W. Larsh, T. H. Linder, J. K. McClatchy, M. R. McGinnis, S. H. Siddiqi, and P. Wright. 1983. Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J. Clin. Microbiol. 18:689-696.
18. Rossau, R., H. Traore, H. De Beenhouwer, W. Mijs, G. Jannes, P. De Rijk, and F. Portaels. 1997. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob. Agents Chemother. 41:2093-2098.
19. Rüsch-Gerdes, S., C. Domehl, G. Nardi, M. R. Gismondo, H.-M. Welscher, and G. E. Pfyffer. 1999. Multicenter evaluation of the mycobacterial growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. J. Clin. Microbiol. 37:45-48.
20. Toungoussova, O. S., P. Sandven, A. O. Mariandyshev, N. I. Nizovtseva, G. Bjune, and D. A. Caugant. 2002. Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J. Clin. Microbiol. 40:1930-1937.
21. Vareldzis, B. P., J. Grosset, I. De Kantor, J. Crofton, A. Laszlo, M. Felten, M. C. Raviglione, and A. Kochi. 1994. Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations. Tuber. Lung Dis. 75:1-7.
22. Walters, S. B., and B. A. Hanna. 1996. Testing of susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by mycobacterium growth indicator tube method. J. Clin. Microbiol. 34:1565-1567.
23. Wanger, A., and K. Mills. 1996. Testing of Mycobacterium tuberculosis susceptibility to ethambutol, isoniazid, rifampin, and streptomycin by using Etest. J. Clin. Microbiol. 34:1672-1676.
24. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO Report 2002. WHO/CDS/TB/2002.295. World Health Organization, Geneva, Switzerland.